FDA Inspection 1272492 — MedisourceRx

MedisourceRx — FEI 3013316698

The FDA completed an inspection of MedisourceRx on June 10, 2025 in Los Alamitos, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 10, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Alamitos, CA (United States)

Citations

IDCFRDescription
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
670521 CFR 310.305(c)Failure to submit ADE report